Document is current
Any future updates will be listed below
-
Authors
Mahmoud, Zainab
Orji, Adaego A.
Okoye, Chukwuebuka F.
Ameh, Friday O.
Jamro-Comer, Erica
Isah, Aliyu
Ekele, Bissallah
Akaba, Godwin
Ojji, Dike B.
Huffman, Mark D.
- License Information
-
More Information
Article History
Received: 4 April 2023
Accepted: 28 August 2023
First Online: 6 September 2023
Declarations
:
: All procedures followed were in accordance with the ethical standards of the ethics committees and institutional review board and the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from each participant prior to enrolment. The study protocol was reviewed and approved by the ethics board of University of Abuja Teaching Hospital, Federal Capital Territory of Nigeria (UATH/HREC/PR/99), and Institutional Review Board at Washington University in St. Louis (IRB ID #202207009).
: Not Applicable.
: ZM receives grant funding from the American College of Cardiology, Association of Black Cardiologists and Merck Foundation. MDH has pending patents for heart failure polypills. George Health Enterprises Pty Ltd (GH) and its subsidiary, George Medicines Pty Ltd, have received investment funds to develop fixed-dose combination products, including combinations of blood pressure-lowering drugs. GH is the social enterprise arm of The George Institute for Global Health. The remaining authors have nothing to disclose.
